LYFIX Holdings — AlphaCentric Life Sciences and Healthcare Fund
Data updated: 2026-08-27
LYFIX holds 62 securities. The top 10 make up 40.7% of net assets, led by Gilead Sciences (5.53%) and Vertex Pharm (5.33%). Health Care (95.7%) and Funds & ETFs (4.3%) are the largest sectors, and 76.0% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 100.09% of net asset value (99.83% of total assets; remainder is cash and receivables). As of June 30, 2026 · N-PORT.
LYFIX Portfolio Holdings
62 holdings of AlphaCentric Life Sciences and Healthcare Fund by percentage of net assets, from the fund's SEC N-PORT filing as of June 30, 2026.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Gilead Sciences | GILD | Health Care | 5.53% | $2.58M |
| Vertex Pharm | VRTX | Health Care | 5.33% | $2.48M |
| Astrazeneca PLC | AZN | Health Care | 4.63% | $2.16M |
| First Am-Tr Ob-X | — | Funds & ETFs | 4.26% | $1.99M |
| Roivant Sciences | ROIV | Health Care | 3.67% | $1.71M |
| Argenx SE - ADR | ARGX | Health Care | 3.59% | $1.68M |
| Neurocrine Biosc | NBIX | Health Care | 3.51% | $1.64M |
| Incyte Corp. | INCY | Health Care | 3.51% | $1.64M |
| Axsome Therapeut | AXSM | Health Care | 3.43% | $1.60M |
| Apogee Therapeut | APGE | Health Care | 3.28% | $1.53M |
| Ionis Pharmaceut | IONS | Health Care | 2.62% | $1.22M |
| Ascendis Pharma | ASND | Health Care | 2.62% | $1.22M |
| Insmed, Inc. | INSM | Health Care | 2.60% | $1.21M |
| Protagonist Ther | PTGX | Health Care | 2.41% | $1.12M |
| Personalis, Inc. | PSNL | Health Care | 2.27% | $1.06M |
| Rhythm Pharmaceu | RYTM | Health Care | 2.25% | $1.05M |
| Abbvie, Inc. | ABBV | Health Care | 1.95% | $909.18K |
| Jazz Pharmaceuti | JAZZ | Health Care | 1.87% | $870.62K |
| Amgen, Inc. | AMGN | Health Care | 1.83% | $855.33K |
| Biogen, Inc. | BIIB | Health Care | 1.80% | $840.69K |
| Catalyst Pharmac | CPRX | Health Care | 1.59% | $742.44K |
| Halozyme Therape | HALO | Health Care | 1.58% | $737.77K |
| Meiragtx Holding | MGTX | Health Care | 1.58% | $735.88K |
| Krystal Biotech | KRYS | Health Care | 1.55% | $722.90K |
| Nuvalent, Inc.-A | NUVL | Health Care | 1.47% | $686.41K |
| Abivax SA-ADR | ABVX | Health Care | 1.47% | $685.09K |
| Edgewise Therape | EWTX | Health Care | 1.38% | $643.58K |
| Nurix Therapeuti | NRIX | Health Care | 1.34% | $627.00K |
| Sanofi-ADR | SNY | Health Care | 1.33% | $622.41K |
| Oruka Therapeuti | ORKA | Health Care | 1.33% | $621.56K |
| Kymera Therapeut | KYMR | Health Care | 1.32% | $617.50K |
| Spyre Therapeuti | SYRE | Health Care | 1.27% | $592.16K |
| Biontech SE-ADR | BNTX | Health Care | 1.25% | $583.05K |
| Agios Pharmaceut | AGIO | Health Care | 1.13% | $525.96K |
| Newamsterdam Pha | NAMS | Health Care | 1.08% | $503.88K |
| Cytokinetics, Inc. | CYTK | Health Care | 1.04% | $485.33K |
| Celldex Therapeu | CLDX | Health Care | 1.02% | $475.69K |
| Trevi Therapeuti | TRVI | Health Care | 0.97% | $453.51K |
| Alnylam Pharmace | ALNY | Health Care | 0.90% | $418.43K |
| Veracyte, Inc. | VCYT | Health Care | 0.87% | $408.06K |
| Candel Therapeut | CADL | Health Care | 0.81% | $377.83K |
| Natera, Inc. | NTRA | Health Care | 0.81% | $377.32K |
| Rezolute, Inc. | RZLT | Health Care | 0.81% | $375.73K |
| Cullinan Therape | CGEM | Health Care | 0.80% | $371.96K |
| Crinetics Pharma | CRNX | Health Care | 0.79% | $369.19K |
| Xeris Biopharma | XERS | Health Care | 0.79% | $368.67K |
| Design Therapeut | DSGN | Health Care | 0.67% | $311.64K |
| Monte Rosa Thera | GLUE | Health Care | 0.66% | $306.01K |
| Disc Medicine in | IRON | Health Care | 0.63% | $294.75K |
| Rapport Therapeu | RAPP | Health Care | 0.58% | $272.15K |
| Arvinas, Inc. | ARVN | Health Care | 0.55% | $254.47K |
| Icon PLC | ICLR | Health Care | 0.52% | $241.46K |
| Tectonic Therape | TECX | Health Care | 0.51% | $238.84K |
| Sionna Therapeut | SION | Health Care | 0.46% | $213.92K |
| Wave Life Scienc | — | Health Care | 0.44% | $207.24K |
| Intellia Therape | NTLA | Health Care | 0.42% | $197.49K |
| Atrium Therapeut | RNA | Health Care | 0.39% | $181.28K |
| Iqvia Holdings I | IQV | Health Care | 0.35% | $161.15K |
| Annexon, Inc. | ANNX | Health Care | 0.30% | $142.02K |
| Adma Biologics I | ADMA | Health Care | 0.18% | $84.90K |
| Aldeyra Therapeu | ALDX | Health Care | 0.17% | $80.21K |
| Alkermes PLC Cvr | — | Health Care | 0.00% | $0 |
LYFIX Sector Allocation
AlphaCentric Life Sciences and Healthcare Fund holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 95.7% | 61 |
| Funds & ETFs | 4.3% | 1 |
LYFIX Country Allocation
Where AlphaCentric Life Sciences and Healthcare Fund's holdings are domiciled, by percentage of net assets (largest 10).
| Country | % of net assets |
|---|---|
| United States | 76.0% |
| Netherlands | 4.7% |
| United Kingdom | 4.6% |
| Bermuda | 3.7% |
| France | 2.8% |
| Denmark | 2.6% |
| Ireland | 2.4% |
| Cayman Islands | 1.6% |
| Germany | 1.2% |
| Singapore | 0.4% |
LYFIX Portfolio Allocation
Asset-class allocation of AlphaCentric Life Sciences and Healthcare Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 95.8% |
| Cash & Equivalents | 4.3% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.